Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.: history, ownership, mission, how it works & makes money

From its founding in Dezhou on December 30, 2005 to its Shanghai Stock Exchange debut in April 2021 under 605016.SS, Shandong Bailong Chuangyuan Bio‑Tech Co., Ltd. has grown into a global supplier of dietary fibers, prebiotics and starch sugars with an annual comprehensive production capacity of about 300,000 tons by December 2025, a registered capital of 177.52 million RMB, and a workforce of 988 employees; the company's certified portfolio (BRCGS, EU/US Organic, KOSHER, HALAL, ISO series, NON‑GMO) and more than 130 patent applications (70+ authorized) underpin an innovation system tied to Shandong University, Jiangnan University and national institutes, while commercial traction is evident in a 2024 revenue of 1.15 billion RMB (up 32.64% year‑over‑year), exports accounting for over 40% of sales, a market capitalization near 8.86 billion RMB (as of 18‑Dec‑2025), a 52‑week stock range of 11.56-23.68 RMB, and recognition as the world's second‑largest prebiotic manufacturer driving products into 50+ countries.

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS): Intro

• Founding date: December 30, 2005 (Dezhou, Shandong)
• Exchange listing: Shanghai Stock Exchange, April 2021 - ticker 605016
• Annual comprehensive production capacity (Dec 2025): ≈300,000 tons

• Dietary fibers: polydextrose, resistant dextrin
• Prebiotics: fructo-oligosaccharide (FOS), isomalto-oligosaccharide (IMO)
• Starch sugars & sugar alcohols: allulose, maltitol
• Feed additives and other functional carbohydrate ingredients

• International and food-safety certifications: BRCGS, EU Organic, US Organic, KOSHER, HALAL
• Management systems: ISO 22000, ISO 9001, ISO 45001, ISO 14001
• Product attribute certifications: NON-GMO

• Long-term institutional collaborations: Shandong University, Jiangnan University, China National Research Institute of Food and Fermentation Industries
• Technical exchanges and resource sharing underpin product development, process optimization and application studies

• 2005: Company founded in Dezhou
• 2021: Listed on Shanghai Stock Exchange (605016.SS)
• 2025: Scaled to ~300,000 tons annual capacity across product lines
• Certifications obtained across global markets enabling export and ingredient adoption

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS): History

• Registered capital: 177.52 million RMB.
• Employees: 988 (total workforce, Dec 2025).
• Listed: Shanghai Stock Exchange, 605016.SS.

Ownership Structure

• Mixed ownership: combination of institutional investors, corporate holdings and individual shareholders.
• Institutional presence: significant holdings by mutual funds, asset managers and industry-related strategic investors contributing to liquidity and governance oversight.
• Public float: actively traded shares on SSE with notable retail investor participation reflected in the 52-week trading range.

Mission

• Core mission: develop and supply safe, effective biotechnology products for agriculture, feed and industrial applications.
• R&D focus: continuous innovation in enzyme technologies, probiotics and fermentation processes to improve yield and sustainability.
• Stakeholder commitments: prioritize product quality, regulatory compliance and long-term value creation for shareholders, customers and communities.

How It Works & Makes Money

• Primary revenue streams:
  • Sales of enzyme preparations and additives to feed and agricultural markets.
  • Probiotic and microbial products for livestock and aquaculture.
  • Custom fermentation and technical services for industrial clients.
• Business model drivers:
  • Manufacturing scale and cost efficiencies enabled by in-house fermentation facilities.
  • R&D-driven product improvements that command premium pricing and recurring orders.
  • Distribution partnerships and direct sales channels across domestic provinces and select exports.
• Financial profile highlights (Dec 2025):
  • Market cap: ≈ 8.86 billion RMB supports access to capital markets for expansion and capex.
  • Stock liquidity and a 52-week range of 11.56-23.68 RMB indicate investor confidence and tradability.

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS): Ownership Structure

• Mission: Supply healthy ingredients and make deep sugar-reduction expertise and a broad ingredient portfolio available to food formulators and manufacturers.
• Core values: innovation, technological advancement, nutrition & health improvement, industry leadership in functional sugar and bio-fermentation.
• Collaborations: long-term technical partnerships with Shandong University, Jiangnan University, and China National Research Institute of Food and Fermentation Industries for research exchanges and resource sharing.

• Research projects: numerous national and industry projects (company frequently participates in provincial and national R&D programs).
• Patents: applied for over 130 patents; more than 70 authorized-63 domestic invention patents and 9 international invention patents (5 U.S., 4 Canada).
• Innovation system: end-to-end pipeline from lab R&D to commercial production enabling faster scale-up of new functional sugar products.

• Product sales: high-margin proprietary functional sugars and oligosaccharides sold in bulk to food manufacturers and ingredient formulators.
• Customization & formulation services: paid R&D and pilot projects with co-development fees and long-term supply contracts.
• Technology licensing & partnerships: licensing patented processes and collaborative commercialization agreements with industrial partners and research institutes.
• Industrialization scale-up: pilot-to-commercial production enables margin improvement and volume growth as new products move into mass production.

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS): Mission and Values

• Founded and listed entity active in specialty biotech manufacturing, with integrated capabilities across R&D, pilot, production and commercialization.
• Ownership: publicly listed on the Shanghai Stock Exchange (ticker 605016.SS), with a shareholder base composed of institutional investors, retail investors and company insiders (standard listed-company governance structure).

Mission

• To develop safe, high-quality biochemical and nutritional ingredients through technological innovation and automated manufacturing, delivering value to partners across food, feed and pharmaceutical supply chains.
• To continuously improve process efficiency and product purity while reducing environmental footprint through advanced engineering and R&D.

How It Works

• Automated production lines: The company operates advanced, highly automated production lines ensuring the entire process-from raw material input to product packaging-is automated, improving throughput, consistency and safety while lowering unit labor costs.
• Integrated innovation system: R&D → pilot testing → incubation → industrialization → commercialization is implemented as a continuous pipeline, allowing rapid scale-up of validated processes.
• Analytical and quality infrastructure: The R&D center is equipped with advanced analytical instruments including Waters HPLC, gas chromatography and ion chromatography to support quality control, method development and product characterization.
• Strategic collaborations: Long-term cooperative relationships with institutions such as Shandong University, Jiangnan University and the China National Research Institute of Food and Fermentation Industries facilitate technical exchanges, access to talent and shared pilot resources.

Intellectual Property, Brands & Recognition

• Research projects undertaken and patent activity: applied for over 130 patents, with more than 70 patents authorized.
• Breakdown of authorized invention patents: 63 domestic invention patents and 9 international invention patents (5 U.S., 4 Canada).
• Trademark portfolio: over 120 registered trademarks, including 22 overseas trademarks.
• Awards: recipient of more than ten provincial and national-level scientific and technological awards recognizing process innovation, product quality and technology transfer.

How It Makes Money

• Product sales: bulk sales of amino acids, specialty nutritional ingredients and biochemical intermediates to food, feed, pharmaceutical and industrial customers-primary revenue driver.
• OEM/contract manufacturing: fee-based production services leveraging automated lines for third-party formulas and scaling pilot processes to full production.
• Technology licensing and IP monetization: licensing of proprietary processes, formulations and patented technologies to partners and joint ventures.
• Value-added formulations and branded products: higher-margin packaged or formulated products sold under registered trademarks in domestic and selected overseas markets.
• R&D partnerships and government/academic collaborations: funded R&D projects and grants supporting pipeline development and cost-sharing of pilot efforts.

Operational and R&D Metrics (Selected)

• IP intensity: >130 patent applications with >70 granted demonstrates a high R&D-to-patent conversion activity.
• Brand reach: >120 trademarks (22 overseas) support cross-border commercialization ambitions.
• Analytical capability: HPLC, GC, ion chromatography in-house for product release and regulatory compliance.

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS): How It Works

• Primary revenue sources: production and sale of dietary fibers, prebiotics, starch sugars, and customized additive blends for food, medicine, health, and feed industries.
• Distribution channels: direct sales, OEM supply to food processors, exports to international distributors, and partnerships with feed manufacturers.
• R&D and product development: collaboration with universities and research institutes to develop application-specific ingredients and improve production yields.

• Raw material procurement: starch and agricultural feedstocks sourced regionally and globally.
• Biochemical processing: enzymatic hydrolysis and fermentation platforms produce functional oligosaccharides, resistant starches, and soluble fibers.
• Formulation & testing: product-specific blending, stability, and safety testing to meet food and pharma standards.
• Packaging & logistics: bulk and consumer-pack formats; cold-chain or dry logistics depending on product.
• Sales & after-sales: technical support to clients for formulation integration and regulatory documentation for export markets.

• Diversified end-markets: food processing, pharmaceuticals, health supplements, and animal feed reduce single-market exposure.
• High-margin specialty ingredients: prebiotics and functional fibers command premium pricing versus commodity starch derivatives.
• Export penetration: with exports making up over 40% of revenue and presence in 50+ countries, the company benefits from global demand and scale.
• R&D-driven product differentiation: over 130 patent applications and long-term cooperation with institutions strengthen proprietary offerings.

• Academic collaborations include Shandong University, Jiangnan University, and the China National Research Institute of Food and Fermentation Industries, enabling technical exchange and pilot-scale validation.
• Applied research projects target improved enzymatic conversion rates, novel prebiotic structures, and feed-grade functional ingredients to enhance animal health and growth performance.

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS): How It Makes Money

• Core revenue streams: contract manufacturing (B2B ingredients), branded finished products (nutritionals & supplements), R&D service fees and licensing of proprietary strains/formulations.
• Value drivers: proprietary patents and trademarks, large-scale production capacity, and scientific collaborations that enable premium pricing and long-term supply contracts.
• Global expansion: active participation in international trade events (e.g., Fi Europe) to drive export sales and OEM partnerships.

• R&D → IP creation: proprietary strains/formulations backed by institutional collaborations and over 70 authorized patents, enabling licensing and product differentiation.
• Manufacturing scale: large-volume ingredient production for domestic and international food, beverage and supplement manufacturers (B2B OEM/B2B2C contracts).
• Branded products & exports: finished-product sales and overseas trademark protections support retail and e‑commerce channels.
• Service & collaboration fees: funded collaborative research, co-development projects, and technical services for partners and customers.